Pembroke Management LTD Trims Stake in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Pembroke Management LTD decreased its holdings in Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 1.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 305,219 shares of the company's stock after selling 4,295 shares during the period. Ryan Specialty comprises approximately 2.5% of Pembroke Management LTD's holdings, making the stock its 16th largest holding. Pembroke Management LTD owned approximately 0.12% of Ryan Specialty worth $19,583,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Principal Financial Group Inc. increased its stake in shares of Ryan Specialty by 115.2% during the fourth quarter. Principal Financial Group Inc. now owns 1,833,209 shares of the company's stock valued at $117,619,000 after buying an additional 981,505 shares during the period. Jennison Associates LLC increased its stake in shares of Ryan Specialty by 60.2% during the third quarter. Jennison Associates LLC now owns 1,025,063 shares of the company's stock valued at $68,054,000 after buying an additional 385,366 shares during the period. Eagle Asset Management Inc. increased its stake in shares of Ryan Specialty by 32.1% during the third quarter. Eagle Asset Management Inc. now owns 1,380,510 shares of the company's stock valued at $98,555,000 after buying an additional 335,180 shares during the period. Charles Schwab Investment Management Inc. increased its stake in shares of Ryan Specialty by 43.9% during the third quarter. Charles Schwab Investment Management Inc. now owns 938,187 shares of the company's stock valued at $62,286,000 after buying an additional 286,380 shares during the period. Finally, JPMorgan Chase & Co. increased its stake in shares of Ryan Specialty by 107.5% during the third quarter. JPMorgan Chase & Co. now owns 459,464 shares of the company's stock valued at $30,504,000 after buying an additional 238,064 shares during the period. Hedge funds and other institutional investors own 84.82% of the company's stock.

Insiders Place Their Bets

In other news, Director Nicholas Dominic Cortezi sold 35,000 shares of the firm's stock in a transaction dated Monday, December 16th. The stock was sold at an average price of $66.71, for a total value of $2,334,850.00. Following the completion of the transaction, the director now directly owns 60,200 shares in the company, valued at $4,015,942. This trade represents a 36.76 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Over the last 90 days, insiders sold 316,451 shares of company stock valued at $20,907,793. 11.10% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

RYAN has been the topic of several research reports. Keefe, Bruyette & Woods cut their price target on Ryan Specialty from $77.00 to $76.00 and set an "outperform" rating on the stock in a research note on Friday. Royal Bank of Canada dropped their price objective on Ryan Specialty from $73.00 to $72.00 and set a "sector perform" rating on the stock in a research report on Friday. Wells Fargo & Company raised their price objective on Ryan Specialty from $64.00 to $69.00 and gave the company an "equal weight" rating in a research report on Friday. Barclays raised their price objective on Ryan Specialty from $76.00 to $88.00 and gave the company an "overweight" rating in a research report on Thursday, November 21st. Finally, Morgan Stanley initiated coverage on Ryan Specialty in a research report on Thursday, December 5th. They set an "overweight" rating and a $90.00 price objective on the stock. One analyst has rated the stock with a sell rating, six have given a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus price target of $74.55.

Ryan Specialty Stock Down 4.4 %

NYSE RYAN traded down $3.05 during trading on Friday, hitting $65.55. The company's stock had a trading volume of 2,425,852 shares, compared to its average volume of 990,822. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.01 and a quick ratio of 1.01. The company has a market cap of $17.16 billion, a PE ratio of 85.13, a P/E/G ratio of 1.21 and a beta of 0.72. The business's 50 day simple moving average is $65.57 and its 200-day simple moving average is $67.26. Ryan Specialty Holdings, Inc. has a fifty-two week low of $45.72 and a fifty-two week high of $75.97.

Ryan Specialty (NYSE:RYAN - Get Free Report) last issued its quarterly earnings results on Thursday, February 20th. The company reported $0.45 earnings per share for the quarter, missing the consensus estimate of $0.47 by ($0.02). The business had revenue of $663.53 million during the quarter, compared to analyst estimates of $658.80 million. Ryan Specialty had a return on equity of 47.90% and a net margin of 10.31%. On average, equities analysts anticipate that Ryan Specialty Holdings, Inc. will post 1.82 EPS for the current fiscal year.

Ryan Specialty Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 18th. Shareholders of record on Tuesday, March 4th will be issued a $0.12 dividend. This represents a $0.48 annualized dividend and a yield of 0.73%. The ex-dividend date of this dividend is Tuesday, March 4th. This is an increase from Ryan Specialty's previous quarterly dividend of $0.11. Ryan Specialty's dividend payout ratio (DPR) is currently 63.77%.

Ryan Specialty Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.